Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

STAAR Surgical Company - Common Stock (NQ: STAA )

24.82 -0.16 (-0.64%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about STAAR Surgical Company - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
STAAR Surgical Announces Milestone Strategic Agreement in U.S. with IQ Laser Vision
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel
From STAAR Surgical Company
Via Business Wire
STAAR Surgical to Report First Quarter Results on May 7, 2024
From STAAR Surgical Company
Via Business Wire
Staar Surgical Stock Climbs The Leadership Ladder With Jump To 84 RS Rating
On Thursday, implantable lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 84, up from 80 a day earlier. 
Via Investor's Business Daily
In-Depth Examination Of 4 Analyst Recommendations For Staar Surgical
Via Benzinga
A Preview Of Staar Surgical's Earnings
Via Benzinga
Analyst Ratings for Staar Surgical
Via Benzinga
Star Surgical Shines as U.S. Outlook Improves for 2024
STAAR Surgical is increasing its outlook and guidance as demand for its signature IOL procedure increases with an aging population 
Via MarketBeat
Apple To $210? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Eye Lens Maker STAAR Surgical Expects Q1 Sales To Beat Consensus
STAAR Surgical reports Q1 2024 net sales surpassing $77 million, with U.S. ICL sales hitting $5 million, the highest since FDA approval in 2022. CEO anticipates fiscal 2024 sales expected at the higher... 
Via Benzinga
Exposures Product Safety
Staar Surgical, A Lasik Rival, Just Crushed Quarterly Views; But Is Its 2026 Target Too Aggressive?
The company makes an implantable lens to help correct vision problems. 
Via Investor's Business Daily
STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024
From STAAR Surgical Company
Via Business Wire
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong preliminary first-quarter net sales guidance. STAAR Surgical shares jumped 13.3%... 
Via Benzinga
STAAR Surgical Celebrates Three Million Lens Milestone at ASCRS Meeting, Unveils New EVO ICL Data and Latest Innovation for 2024
From STAAR Surgical Company
Via Business Wire
Nvidia’s Market Cap Myopia: 3 Stocks Proving Size Isn’t Everything
These three alternatives to Nvidia stock combined are smaller than the chipmaker but are worth it when considering Nvidia's market cap. 
Via InvestorPlace
STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Adds Arthur Butcher and Wei Jiang to Board of Directors
From STAAR Surgical Company
Via Business Wire
Netflix To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart... 
Via Benzinga
Exposures Product Safety
STAAR Surgical to Participate in Two Upcoming Investor Conferences
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Reports Fourth Quarter and Fiscal Year 2023 Results
From STAAR Surgical Company
Via Business Wire
Earnings Scheduled For February 26, 2024
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on revenue of $477.73 million. 
Via Benzinga
STAAR Surgical to Report Fourth Quarter Results on February 26, 2024
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Announces Strategic Agreement in U.S. with SharpeVision
From STAAR Surgical Company
Via Business Wire
Insiders Buying KalVista Pharmaceuticals And 3 Other Stocks
Although U.S. stocks closed higher on Wednesday, there were a few notable insider trades. 
Via Benzinga
$6.5M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
Although U.S. stocks closed slightly higher on Friday, there were a few notable insider trades. 
Via Benzinga
STAAR Surgical Announces Preliminary Results for Fourth Quarter and Fiscal 2023
From STAAR Surgical Company
Via Business Wire
7 Stocks with Strong Insider Buying: December 2023
Here are just a few of the top stocks with strong insider buying that all investors may want to watch heading into 2024. 
Via InvestorPlace
Lilian Zhou Appointed to STAAR Surgical Board of Directors
From STAAR Surgical Company
Via Business Wire
STAAR Surgical to Present at Stephens Annual Investment Conference (NASH2023)
From STAAR Surgical Company
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.